Stem Cell-Based Interventions for Retinal Ganglion Cell Protection and Regeneration in Glaucoma: A Review of Current Evidence and Future Directions
Ophthalmic Research · 02.06.2026 · 69 (1) · 237-251
DOI: 10.1159/000552109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ophthalmic Research, online erschienen am 02.06.2026. Verfasst von Tony Yihao Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Glaucoma, Stem Cell Transplantation, Nerve Regeneration. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Glaucoma is one of the leading causes of irreversible blindness due to the ongoing loss of retinal ganglion cells (RGCs) and degeneration of the axons that form a major part of the retino-cortical pathway. Although there are some therapies available that primarily ameliorate the intraocular pressure, loss of sight often continues, and thus illustrates the need for therapies that address the degeneration of the nervous system. Summary: Stem cell interventions have the unique potential to assist with the preservation and restoration of dysfunctional RGCs via direct cellular replacement, differential neuroprotection, and stimulation of endogenous repair mechanisms. The focus of this review is on the most contemporary innovations which utilize stem cells to preserve and regenerate RGCs, which are vitally important for sight. The review addresses some of the newer cell source and cell prep technologies, particularly those using disorganized retinal microenvironment cell preps. Retinal microenvironment cell preps have resulted in some novel microenvironment cells designed to sequester stem cell grafts, to improve stem cell microenvironment cell preps, and to augment microenvironment cell preps. Some of the major challenges are reconstructing and integrating the lost retino-tectal and retino-collateral synapses in the visual pathway and the axonal outgrowth to and targeting appropriate central visual synaptic areas. Key Messages: Some major challenges are safety, RGC immunochemistry and cell type diversity, and scalable cell prep technologies. This review encapsulates how stem cell biology, along with other technologies like gene editing and tissue engineering, is forming the basis for developing first-of-its-kind regenerative therapies to restore vision in glaucoma patients, based on recent preclinical studies and ongoing early-phase clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Science, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.
- Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China.
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
- Department of R&D, Shanghai Qiyusenyuan Medical Technology Development Co., Ltd. No. 80, Shanghai, China.
- Department of Ophthalmology and Visual Science, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China, xhsun@shmu.edu.cn.
Zitieren
APA
Chen, T. Y., Meng, M., Wu, N., Rong, D., & Sun, X. (2026). Stem Cell-Based Interventions for Retinal Ganglion Cell Protection and Regeneration in Glaucoma: A Review of Current Evidence and Future Directions. Ophthalmic Research, 69(1), 237-251. https://doi.org/10.1159/000552109
Vancouver
Chen TY, Meng M, Wu N, Rong D, Sun X. Stem Cell-Based Interventions for Retinal Ganglion Cell Protection and Regeneration in Glaucoma: A Review of Current Evidence and Future Directions. Ophthalmic Research. 2026;69(1):237-251. doi:10.1159/000552109
BibTeX
@article{Chen2026,
author = {Chen, Tony Yihao and Meng, Martin and Wu, Na and Rong, Daqian and Sun, Xinghuai},
title = {Stem Cell-Based Interventions for Retinal Ganglion Cell Protection and Regeneration in Glaucoma: A Review of Current Evidence and Future Directions},
journal = {Ophthalmic Research},
year = {2026},
volume = {69},
number = {1},
pages = {237--251},
doi = {10.1159/000552109}
}
EUVIMED